发明名称 CARBAZOLE COMPOUNDS USEFUL AS BROMODOMAIN INHIBITORS
摘要 The present invention is directed to carbazole compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
申请公布号 US2014256700(A1) 申请公布日期 2014.09.11
申请号 US201414190477 申请日期 2014.02.26
申请人 BRISTOL-MYERS SQUIBB COMPANY 发明人 Poss Michael A.;Tortolani David R.;Dodd Dharmpal S.;Mussari Christopher P.;Tokarski John S.;Gavai Ashvinikumar V.;Zhao Yufen;Delucca George V.;O'Malley Daniel;Norris Derek J.;Gill Patrice;Quesnelle Claude A.;Han Wen-Ching
分类号 A61K31/553;A61K31/5377;C07D417/14;C07D413/14;A61K31/422;A61K31/4192;A61K31/496;A61K31/427;A61K31/5355;A61K31/541;C07D405/14;C07D413/04;A61K31/454 主分类号 A61K31/553
代理机构 代理人
主权项 1. A compound of the formulawherein: A is optionally substituted heteroaryl or optionally substituted heterocyclo, wherein the substituents are one or more R14, R15 or R16; R is hydrogen, optionally substituted (C1-C6)alkyl, optionally substituted (C3-C8)cycloalkyl(C1-C6)alkyl, optionally substituted aryl(C1-C6)alkyl, optionally substituted heteroaryl(C1-C6)alkyl, optionally substituted heterocyclo(C1-C6)alkyl, optionally substituted (C1-C6)alkyl-CO—, optionally substituted aryl-CO—, optionally substituted (C3-C8)cycloalkyl-CO—, optionally substituted heteroaryl, optionally substituted heterocyclo-CO—, optionally substituted aryl-SO2—, optionally substituted (C1-C6)alkyl-SO2—, optionally substituted (C3-C8)cycloalkyl-SO2—, optionally substituted heteroaryl-SO2—, optionally substituted (C1-C6)alkyl-OCO— or optionally substituted (C3-C8)cycloalkyl-OCO—; or R is wherein X and Y are independently selected from hydrogen, optionally substituted (C1-C6)alkyl, optionally substituted (C3-C8)cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heterocyclo; Z is hydrogen, halogen, —OH, (C1-C6)alkyl, (C1-C6)alkoxy, —NR3R4, —CONR3R4, —OCONR3R4, —NR6OCOR3, —NR6CONR3R4, —NR6SO2NR3R4 or —NR6SO2R4; R1 is halogen, —CN, OH, —NR3R4, —CONR3R4, —COOH, —OCONR3R4, —NHOCOR7, —NHCONR7R8, —NHSO2NR7R8, optionally substituted (C1-C6)alkyl, optionally substituted (C2-C6)alkenyl, optionally substituted (C2-C6)alkynyl, optionally substituted (C1-C6)alkoxy, optionally substituted (C3-C8)cycloalkyl, optionally substituted (C3-C8)cycloalkyl-CO—, optionally substituted (C3-C8)cycloalkyl-SO2—, optionally substituted aryl (C1-C6)alkoxy, optionally substituted (C3-C8)cycloalkyl (C1-C6)alkoxy, optionally substituted heterocyclyl-CO—, optionally substituted heterocyclyl, optionally substituted (C1-C6)alkyl-SO2—, —NHSO2-optionally substituted (C1-C6)alkyl, —NHSO2-optionally substituted heterocyclo, optionally substituted (C1-C6)alkyl-NHSO2— or optionally substituted heterocyclo-NHSO2—; R2 is H, halogen, —CN, —COOH, —CONR7R8, —NHCOR3R4, —OCONR3R4, —NHCOOR3R4, optionally substituted (C1-C6)alkyl, optionally substituted (C2-C6)alkynyl, optionally substituted (C1-C6)alkoxy, optionally substituted heteroaryl or optionally substituted heterocyclo; R3 is hydrogen, optionally substituted (C1-C6)alkyl, optionally substituted (C3-C8)cycloalkyl, optionally substituted (C2-C6)alkenyl, optionally substituted (C2-C6)alkynyl, cyano(C1-C6)alkyl, hydroxy(C1-C6)alkyl, optionally substituted aryl, optionally substituted aryl(C1-C6)alkyl, optionally substituted aryloxy(C1-C6)alkyl, optionally substituted (C1-C6)alkyl-SO2—, optionally substituted heterocyclyl, optionally substituted heterocyclyl(C1-C6)alkyl, optionally substituted heteroaryl or optionally substituted heteroaryl(C1-C6)alkyl, R4 is hydrogen, optionally substituted (C1-C6)alkyl or optionally substituted (C3-C8)cycloalkyl; or R3 and R4 may be taken together with the nitrogen atom to which they are attached to form an optionally substituted (C4-C8)heteroaryl or (C4-C8)heterocyclic ring; R6 is hydrogen or optionally substituted (C1-C6)alkyl; R7 and R8 are independently hydrogen, optionally substituted (C1-C6)alkyl, optionally substituted (C3-C8)cycloalkyl, optionally substituted (C2-C6)alkenyl, optionally substituted (C2-C6)alkynyl, cyano(C1-C6)alkyl, hydroxy(C1-C6)alkyl, optionally substituted aryl, optionally substituted aryl(C1-C6)alkyl, optionally substituted aryloxy(C1-C6)alkyl, optionally substituted (C1-C6)alkyl-SO2—, optionally substituted heterocyclyl, optionally substituted heterocyclyl(C1-C6)alkyl, optionally substituted heteroaryl or optionally substituted heteroaryl(C1-C6)alkyl; or R7 and R8 may be taken together with the nitrogen atom to which they are attached to form an optionally substituted (C4-C8)heteroaryl or (C4-C8)heterocyclic ring; R12 and R13 are independently hydrogen, halogen, —CN, OH, —CONR3R4, —NHCOOR4, —NHCONR3R4, —NHCOR4, —NHSO2R7, —SO2NR3R4, —NHSO2NR3R4, —SO2R7, optionally substituted (C1-C6)alkyl, optionally substituted (C3-C8)cycloalkyl, optionally substituted (C1-C6)alkoxy, optionally substituted aryl, optionally substituted heteroaryl or optionally substituted heterocyclo; R14 is hydrogen, optionally substituted(C1-C6)alkyl, (C1-C6)alkoxy, halogen, —CN, —NR3R4, OH, —NHOCOR7, —OCONR7R8, —NHCONR7R8 or —CF3; R15 is hydrogen, optionally substituted(C1-C6)alkyl, (C1-C6)alkoxy, halogen, —CN, —NR3R4, OH, —NHOCOR7, —OCONR7R8, —NHCONR7R8 or —CF3; R16 is hydrogen, optionally substituted(C1-C6)alkyl, (C1-C6)alkoxy, halogen, —CN, —NR3R4, OH, —NHOCOR7, —OCONR7R8, —NHCONR7R8 or —CF3; with the proviso that only one of R14, R15 and R16 is hydrogen; and/or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof.
地址 Princeton NJ US